MEI Pharma
$2.209876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.08 (-3.51%) Today
$0.00 (0.00%) As of 4:49 PM EST after-hours
Why Robinhood?
You can buy or sell MEI Pharma and other stocks, options, ETFs, and crypto commission-free!
About MEIP
MEI Pharma, Inc. engages in the clinical development of therapies for cancer. Its drug candidates includes Pracinostat, an oral HDAC inhibitor that is being developed in combination with azacitidine for the treatment of acute myeloid leukemia and myelodysplastic syndrome. Read More Its pipeline also consists of ME-401, an oral PI3K delta inhibitor; Voruciclib, an oral CDK inhibitor; and ME-344, a mitochondrial inhibitor. The company was founded on December 1, 2000 and is headquartered in San Diego, CA.
Employees
40
Headquarters
San Diego, California
Founded
2000
Market Cap
253.34M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
372.77K
High Today
$2.36
Low Today
$2.18
Open Price
$2.23
Volume
416.15K
52 Week High
$3.41
52 Week Low
$1.44
Collections
MEIP Earnings
-$0.36
-$0.24
-$0.12
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Expected May 7, After Hours
People Also Bought
Viking Therapeutics
39,315
$6.56
-3.95%Aurora Cannabis
672,305
$1.50
-3.23%Verastem
17,627
$1.93
-6.31%Corbus Pharmaceuticals
49,191
$5.17
-6.00%Inovio
60,467
$3.80
-4.04%Geron
31,467
$1.15
-4.17%Aurinia Pharmaceuticals
11,423
$18.12
-5.92%Rigel Pharmaceuticals
8,585
$2.15
-2.27%Hexo
166,386
$1.26
-3.82%Novavax
15,321
$7.86
-3.73%TherapeuticsMD
13,640
$1.90
0.00%Aphria
99,991